CoChat

Targeting epigenetic regulators to overcome drug resistance in the emerging human fungal pathogen Candida auris

Open access
Zhang, Yuping, Zeng, Lingbing, Huang, Xinhua, Wang, Yuanyuan, Chen, Guangsheng, Moses, Munika, Zou, Yun, Xiong, Sichu, Xue, Wenwen, Dong, Yanmei, Tian, Yueru, Guan, Ming, Hu, Lingfei, Yin, Zhe, Zhou, Dongsheng, Huang, Xiaotian, Chen, Changbin · 2025 · Nature Communications

Published version of a preprint

The DOI matches its Crossref record; 80 of the 81 references it cites were found in a registry or an index; 23 of the 42 sources its claims cite were checked for support.

Abstract

GCN5 depletion and loss of histone H3 acetylation downregulate key genes involved in ergosterol biosynthesis and drug efflux and regulate cell wall integrity and echinocandin resistance through calcineurin signaling and Cas5.

Overview

CoChat Summary

TL;DR

This study systematically examines histone H3 post-translational modification writers in *Candida auris* and identifies the acetyltransferase Gcn5 as a key regulator of antifungal resistance and virulence. Gcn5 inhibition with CPTH2 synergizes with caspofungin in vitro and in vivo, supporting Gcn5 as a potential therapeutic target.

Key findings

  • GCN5 deletion in *C. auris* increased sensitivity to echinocandins, azoles, and polyenes; RNA-seq of WT versus gcn5Δ identified 975 differentially expressed genes (517 upregulated, 458 downregulated), with GSEA showing enrichment of ergosterol biosynthesis (NES 2.43, nominal and FDR-adjusted p < 0.0001).
  • Gcn5 regulates azole resistance via ergosterol biosynthesis genes (ERG11, ERG1, ERG3, ERG25, UPC2) and drug efflux pumps (CDR1, SNQ2, MDR1), and regulates echinocandin resistance through the calcineurin pathway and transcription factor Cas5; gcn5Δ showed cell wall defects and elevated Hog1, Mkc1, and Cek1 phosphorylation.
  • In infection models, GCN5 deletion reduced virulence in *Galleria mellonella* and immunosuppressed mice, with higher survival and lower organ fungal burden; CPTH2 plus caspofungin showed synergy (FICI < 0.5) against most *C. auris* clades except clade II and reduced fungal burden in kidneys and liver compared with caspofungin alone.
  • CPTH2 inhibited *C. auris* Gcn5 at 1 µM versus 400 µM in mammalian cells; in mice, CPTH2 at 10, 20, or 40 mg/kg/day for 4 days caused no weight loss and no significant changes in ALT, AST, CREA, BUN, or LDH.

Methods

  • Genetic knockouts and complementation were constructed in *C. auris* strains CBS12767 and yCB799; assays included Western blot for histone H3 acetylation/methylation, qRT-PCR, RNA-seq, ChIP-qPCR, CLSI M27-A4 broth microdilution, checkerboard assays, time-kill curves, Rhodamine 6G efflux, Calcofluor White chitin staining, and MAPK phosphorylation Western blots.
  • Infection models used *Galleria mellonella* larvae and immunosuppressed ICR or C57BL/6 mice; outcomes included survival curves and fungal burden in organs after treatment with caspofungin, fluconazole, CPTH2, or combinations.
  • Statistical analyses used GraphPad PRISM 9.4.1; RNA-seq differential expression used DESeq2 with adjusted p < 0.05 and |log2 fold change| > 1, and GO enrichment used clusterProfiler.

Limitations

  • The paper states that the exact mechanisms by which Gcn5 influences pathogenicity remain partially elucidated, that further research is needed to confirm safety observations, and that site-directed mutagenesis is needed to explore specific Gcn5-regulated histone H3 acetylation sites.
  • The paper notes that whether prolonged CPTH2 exposure leads to evolved resistance within Gcn5 itself or activation of compensatory pathways remains an open question; it also states that how Gcn5 regulates Cna1 and whether Cas5 overexpression or phosphorylation-site mutations restore echinocandin resistance in cna1Δ mutants require further study.
  • The paper reports that CPTH2 plus caspofungin did not significantly affect spleen or lung fungal burden and did not improve survival or survival time in immunosuppressed mice infected with yCB799; synergy was not observed in clade II, and the study did not involve sex-based analysis.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41467-025-59898-6

Cites

80 of 81 references verified1 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Methylation and acetylation of histone H3 in C. auris respond to antifungal drug stress. a, b Treatment of C. auris fluconazole-resistant strain CBS12767 with 100 ng/mL CAS (caspofungin), 128 μg/mL FLC (fluconazole), 8 μg/mL 5-FC (5-fluorocytosine), or an equal volume of DMSO for 1 h. Western blot was used to detect changes in acetylation (a) and methylation (b) levels of histone H3. c, d Treatment of C. auris fluconazole-resistant strain CBS12767 (c) or echinocandin-resistant strain yCB799 (d) with 100 ng/mL or 8 μg/mL CAS, 128 μg/mL FLC, 8 μg/mL 5-FC, and an equal volume of DMSO for 0, 0.5, 1, and 2 h. qRT-PCR was used to detect changes in transcription levels of genes GCN5, RTT109, SET1, SET2, and DOT1. e-i Western blot was used to detect changes in acetylation or methylation levels of histone H3 corresponding to each gene knockout strain and GCN5-complemented strain (GCN5 AB). Each experiment was independently repeated twice with consistent results. #1 and #2 denote two independently constructed knockout strains. Data presented in (a-d) are expressed as mean ± SD and are representative of two or three independent experiments. Statistical significance analysis was performed using one-way ANOVA with Sidak’s test. Source data are provided as a Source Data file.
Fig. 1 Methylation and acetylation of histone H3 in C. auris respond to antifungal drug stress. a, b Treatment of C. auris fluconazole-resistant strain CBS12767 with 100 ng/mL CAS (caspofungin), 128 μg/mL FLC (fluconazole), 8 μg/mL 5-FC (5-fluorocytosine), or an equal volume of DMSO for 1 h. Western blot was used to detect changes in acetylation (a) and methylation (b) levels of histone H3. c, d Treatment of C. auris fluconazole-resistant strain CBS12767 (c) or echinocandin-resistant strain yCB799 (d) with 100 ng/mL or 8 μg/mL CAS, 128 μg/mL FLC, 8 μg/mL 5-FC, and an equal volume of DMSO for 0, 0.5, 1, and 2 h. qRT-PCR was used to detect changes in transcription levels of genes GCN5, RTT109, SET1, SET2, and DOT1. e-i Western blot was used to detect changes in acetylation or methylation levels of histone H3 corresponding to each gene knockout strain and GCN5-complemented strain (GCN5 AB). Each experiment was independently repeated twice with consistent results. #1 and #2 denote two independently constructed knockout strains. Data presented in (a-d) are expressed as mean ± SD and are representative of two or three independent experiments. Statistical significance analysis was performed using one-way ANOVA with Sidak’s test. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 2 Significant impact on antifungal drug resistance in C auris due to disruption of the GCN5 gene encoding histone H3 acetyltransferase. a, b Spot assay comparing the growth differences of C. auris CBS12767, gcn5Δ, and GCN5 AB (a) or yCB799 and gcn5Δ-2 (b) under antifungal drug stress with CAS (caspofungin), MCF (micafungin), FLC (fluconazole), VOC (voriconazole), ITC (itraconazole), AmB (amphotericin B), or 5-FC (5-fluorocytosine). c Microdilution method to test the effects of antifungal drugs CAS, MCF, FLC, VOC, ITC, AmB, or 5-FC in YPD liquid medium on the growth of C. auris CBS12767, gcn5Δ, and GCN5 AB. d, e Time-kill curves of CAS (d) or MCF (e) in YPD liquid medium on C. auris CBS12767, gcn5Δ, and GCN5 AB strains. Data presented in (d, e) are expressed as mean ± SD and are representative of three independent experiments. Source data are provided as a Source Data file.
Fig. 2 Significant impact on antifungal drug resistance in C auris due to disruption of the GCN5 gene encoding histone H3 acetyltransferase. a, b Spot assay comparing the growth differences of C. auris CBS12767, gcn5Δ, and GCN5 AB (a) or yCB799 and gcn5Δ-2 (b) under antifungal drug stress with CAS (caspofungin), MCF (micafungin), FLC (fluconazole), VOC (voriconazole), ITC (itraconazole), AmB (amphotericin B), or 5-FC (5-fluorocytosine). c Microdilution method to test the effects of antifungal drugs CAS, MCF, FLC, VOC, ITC, AmB, or 5-FC in YPD liquid medium on the growth of C. auris CBS12767, gcn5Δ, and GCN5 AB. d, e Time-kill curves of CAS (d) or MCF (e) in YPD liquid medium on C. auris CBS12767, gcn5Δ, and GCN5 AB strains. Data presented in (d, e) are expressed as mean ± SD and are representative of three independent experiments. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 3 Gcn5 regulates both ergosterol synthesis and drug efflux pump activity in C. auris. a-d Transcriptomic sequencing of C. auris CBS12767 or gcn5Δ treated with 256 μg/mL FLC (fluconazole) or an equal volume of DMSO for 2 h. a Volcano plot showing differentially expressed genes between gcn5Δ and CBS12767. Statistical analysis was performed using DESeq2 (two-sided Wald test), with multiple testing correction via the Benjamini–Hochberg method. b Heatmap illustrating expression changes in genes related to ergosterol biosynthesis and drug efflux pumps. c GSEA analysis revealed significant enrichment of the ergosterol biosynthesis pathway in differentially expressed genes between gcn5Δ and CBS12767. Statistical significance was determined using a two-sided permutation test (1000 permutations). The normalized enrichment score (NES) was 2.43, with both nominal and FDR-adjusted p-values < 0.0001. d qRT-PCR validation of selected genes involved in ergosterol synthesis (ERG11, ERG1, ERG3, ERG25, UPC2) and drug efflux (CDR1, SNQ2, MDR1) in CBS12767, gcn5Δ, and GCN5 AB. e, f Gcn5-dependent H3K14Ac at the promoter regions of ERG11 and CDR1 assessed by ChIP-qPCR. e Schematic of H3K14Ac enrichment at different positions in the ERG11 promoter (top); Detection of H3K14Ac enrichment in the ERG11 gene promoter region of C. auris CBS12767 or gcn5Δ (bottom left); Fluconazole-induced changes in H3K14Ac levels at the ERG11 promoter of C. auris CBS12767 over time (30, 60, 120 min) (bottom right). f Similar analysis for the CDR1 promoter. g, h R-6G (Rhodamine 6-G) efflux assay testing drug efflux pump activity in C. auris CBS12767, gcn5Δ, and GCN5 AB, with consistent results across two independent repeats. g shows photos of pellets after starvation, dye uptake, glucose stimulation, and centrifugation. h presents the same samples viewed under fluorescence microscopy in the RFP channel. Data presented in (d-f) are expressed as mean ± SD and are representative of three independent experiments. Statistical significance analysis was performed using two-way ANOVA (d) or one-way ANOVA (e, f) with Sidak’s test. Source data are provided as a Source Data file.
Fig. 3 Gcn5 regulates both ergosterol synthesis and drug efflux pump activity in C. auris. a-d Transcriptomic sequencing of C. auris CBS12767 or gcn5Δ treated with 256 μg/mL FLC (fluconazole) or an equal volume of DMSO for 2 h. a Volcano plot showing differentially expressed genes between gcn5Δ and CBS12767. Statistical analysis was performed using DESeq2 (two-sided Wald test), with multiple testing correction via the Benjamini–Hochberg method. b Heatmap illustrating expression changes in genes related to ergosterol biosynthesis and drug efflux pumps. c GSEA analysis revealed significant enrichment of the ergosterol biosynthesis pathway in differentially expressed genes between gcn5Δ and CBS12767. Statistical significance was determined using a two-sided permutation test (1000 permutations). The normalized enrichment score (NES) was 2.43, with both nominal and FDR-adjusted p-values < 0.0001. d qRT-PCR validation of selected genes involved in ergosterol synthesis (ERG11, ERG1, ERG3, ERG25, UPC2) and drug efflux (CDR1, SNQ2, MDR1) in CBS12767, gcn5Δ, and GCN5 AB. e, f Gcn5-dependent H3K14Ac at the promoter regions of ERG11 and CDR1 assessed by ChIP-qPCR. e Schematic of H3K14Ac enrichment at different positions in the ERG11 promoter (top); Detection of H3K14Ac enrichment in the ERG11 gene promoter region of C. auris CBS12767 or gcn5Δ (bottom left); Fluconazole-induced changes in H3K14Ac levels at the ERG11 promoter of C. auris CBS12767 over time (30, 60, 120 min) (bottom right). f Similar analysis for the CDR1 promoter. g, h R-6G (Rhodamine 6-G) efflux assay testing drug efflux pump activity in C. auris CBS12767, gcn5Δ, and GCN5 AB, with consistent results across two independent repeats. g shows photos of pellets after starvation, dye uptake, glucose stimulation, and centrifugation. h presents the same samples viewed under fluorescence microscopy in the RFP channel. Data presented in (d-f) are expressed as mean ± SD and are representative of three independent experiments. Statistical significance analysis was performed using two-way ANOVA (d) or one-way ANOVA (e, f) with Sidak’s test. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 4 Gcn5 regulates echinocandin drug resistance and cell wall structure homeostasis in C. auris by modulating the calcineurin pathway and the transcription factor Cas5. a, b qRT-PCR was used to measure expression levels of the FKS1, FKS2 and RHO1genes (a) and the CAS5 and CRZ1 genes (b) in C. auris strains CBS12767, gcn5Δ, and GCN5 AB. c Spot assay comparing growth differences of C. auris CBS12767, gcn5Δ, cas5Δ, crz1Δ, and cna1Δ (top) or C. auris yCB799, gcn5Δ−2, cas5Δ−2, crz1Δ−2, and cna1Δ−2 (bottom) under 100 ng/mL or 2 μg/mL CAS and 300 mM CaCl2 conditions. d Spot assay assessing growth differences of C. albicans SN250, gcn5Δ/Δ, gcn5Δ/Δ+CAS5OE, gcn5Δ/Δ+CNA1OE and gcn5Δ/Δ+CRZ1OE under 40 ng/mL or 50 ng/mL CAS (caspofungin) conditions. e qRT-PCR analysis of expression changes in genes related to fungal cell wall integrity regulated by the transcription factor Cas5. f Spot assay detecting growth differences of C. auris CBS12767, gcn5Δ, and GCN5 AB strains under cell wall stress conditions of 30 μg/mL CFW (Calcofluor White) or 0.1% W/V SDS (Sodium Dodecyl Sulfate). g Fluorescence microscopy using the UW channel to observe chitin distribution in the cell walls of C. auris CBS12767, gcn5Δ, and GCN5 AB after staining with CFW. The experiment was independently repeated twice with consistent results. h Western blot analysis of phosphorylation levels of MAPK pathway kinases Hog1, Mkc1, and Cek1 in C. auris CBS12767, gcn5Δ, and GCN5 AB growth under normal conditions or after treatment with 100 ng/mL CAS for 30 or 60 min. The experiment was independently repeated twice with consistent results. Data presented in (a–e) are expressed as mean ± SD and represent of three independent experiments. Statistical significance analysis was performed using two-way ANOVA with Sidak’s test. Source data are provided as a Source Data file.
Fig. 4 Gcn5 regulates echinocandin drug resistance and cell wall structure homeostasis in C. auris by modulating the calcineurin pathway and the transcription factor Cas5. a, b qRT-PCR was used to measure expression levels of the FKS1, FKS2 and RHO1genes (a) and the CAS5 and CRZ1 genes (b) in C. auris strains CBS12767, gcn5Δ, and GCN5 AB. c Spot assay comparing growth differences of C. auris CBS12767, gcn5Δ, cas5Δ, crz1Δ, and cna1Δ (top) or C. auris yCB799, gcn5Δ−2, cas5Δ−2, crz1Δ−2, and cna1Δ−2 (bottom) under 100 ng/mL or 2 μg/mL CAS and 300 mM CaCl2 conditions. d Spot assay assessing growth differences of C. albicans SN250, gcn5Δ/Δ, gcn5Δ/Δ+CAS5OE, gcn5Δ/Δ+CNA1OE and gcn5Δ/Δ+CRZ1OE under 40 ng/mL or 50 ng/mL CAS (caspofungin) conditions. e qRT-PCR analysis of expression changes in genes related to fungal cell wall integrity regulated by the transcription factor Cas5. f Spot assay detecting growth differences of C. auris CBS12767, gcn5Δ, and GCN5 AB strains under cell wall stress conditions of 30 μg/mL CFW (Calcofluor White) or 0.1% W/V SDS (Sodium Dodecyl Sulfate). g Fluorescence microscopy using the UW channel to observe chitin distribution in the cell walls of C. auris CBS12767, gcn5Δ, and GCN5 AB after staining with CFW. The experiment was independently repeated twice with consistent results. h Western blot analysis of phosphorylation levels of MAPK pathway kinases Hog1, Mkc1, and Cek1 in C. auris CBS12767, gcn5Δ, and GCN5 AB growth under normal conditions or after treatment with 100 ng/mL CAS for 30 or 60 min. The experiment was independently repeated twice with consistent results. Data presented in (a–e) are expressed as mean ± SD and represent of three independent experiments. Statistical significance analysis was performed using two-way ANOVA with Sidak’s test. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 5 Gcn5 is essential for the virulence of C. auris in invasive infections in mice. a Schematic diagram outlining the procedure for generating survival curves. b Thirty-day survival curve of immunosuppressed ICR mice (n = 8) after intravenous infection with C. auris CBS12767, gcn5Δ, or GCN5 AB, monitored daily for mortality. c Schematic diagram illustrating the method for measuring fungal burden in organs. d Assessment of fungal burden in the kidneys, spleen, liver, brain, and lungs of immunosuppressed ICR mice (n = 4) 3 days post-infection with C. auris CBS12767, gcn5Δ, or GCN5 AB, quantified using CFU counts. Data presented in (d) are expressed as mean ± SD. Statistical significance analysis was performed using Log-rank (Mantel-Cox) test (b) or one-way ANOVA with Sidak’s test (d). Source data are provided as a Source Data file.
Fig. 5 Gcn5 is essential for the virulence of C. auris in invasive infections in mice. a Schematic diagram outlining the procedure for generating survival curves. b Thirty-day survival curve of immunosuppressed ICR mice (n = 8) after intravenous infection with C. auris CBS12767, gcn5Δ, or GCN5 AB, monitored daily for mortality. c Schematic diagram illustrating the method for measuring fungal burden in organs. d Assessment of fungal burden in the kidneys, spleen, liver, brain, and lungs of immunosuppressed ICR mice (n = 4) 3 days post-infection with C. auris CBS12767, gcn5Δ, or GCN5 AB, quantified using CFU counts. Data presented in (d) are expressed as mean ± SD. Statistical significance analysis was performed using Log-rank (Mantel-Cox) test (b) or one-way ANOVA with Sidak’s test (d). Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 6 The gcn5Δ mutant is more effectively cleared by CAS treatment in vivo. a Schematic diagram outlining the experimental procedure. b Assessment of fungal burden in the kidneys, spleen, liver, and lungs of mice following treatment with 4 doses (top) or 8 doses (bottom) of CAS (n = 4). Fungal burden was measured using CFU counts. Data are expressed as mean ± SD. Statistical significance analysis was performed using one-way ANOVA with Sidak’s test. Source data are provided as a Source Data file.
Fig. 6 The gcn5Δ mutant is more effectively cleared by CAS treatment in vivo. a Schematic diagram outlining the experimental procedure. b Assessment of fungal burden in the kidneys, spleen, liver, and lungs of mice following treatment with 4 doses (top) or 8 doses (bottom) of CAS (n = 4). Fungal burden was measured using CFU counts. Data are expressed as mean ± SD. Statistical significance analysis was performed using one-way ANOVA with Sidak’s test. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 7 Synergistic antifungal effect of CPTH2 and CAS against C. auris in vitro and in vivo. a Histone H3 acetylation levels in C. auris CBS12767 were assessed by Western blot following treatment with increasing concentrations of CPTH2 or DMSO control. Results are representative of three independent experiments. b Spot assays show the individual and combined antifungal effects of CPTH2 (0.5 μM) and CAS (31.25 ng/mL for CBS12767; 4 μg/mL for yCB799) against C. auris CBS12767 and yCB799. c, d Checkerboard assays evaluated CPTH2 and CAS combinations against CBS12767 (c) and yCB799 (d). FICI values are shown in the upper right corners. e, g Time-kill curves for CPTH2 and CAS, alone or in combination, were generated for CBS12767 (e) and yCB799 (g). Combo1 and Combo2 indicate 4 μM CPTH2 with 7.8 or 31.25 ng/mL CAS (e), and 6 μM CPTH2 with 8 or 128 μg/mL CAS (g). Data are representative of three independent experiments. f, h Colony formation after 48-h drug exposure (alone or combined) and plating on drug-free SDA medium, followed by 36-h incubation at 30 °C for CBS12767 (f) and yCB799 (h). i, j Checkerboard assays demonstrate synergistic activity of CPTH2 and CAS against clinical isolates from five C. auris clades (i) and the gcn5Δ−2 mutant (j), with FICI values in the upper right corner; I, II, III, IV, and V represent Clades I–V. k Survival analysis of Galleria mellonella larvae (n = 20) infected with yCB799 and treated with CPTH2 alone (upper panel) or CPTH2 and CAS alone or in combination (lower panel). l Fungal burden measured in the spleens and liver of mice infected with yCB799 after 6 treatments with CPTH2 (10 mg/kg, n = 6; 40 mg/kg, n = 8) and CAS (10 mg/kg), either alone or in combination. Data presented in (a–k) are expressed as mean ± SD. Statistical significance analysis was performed using Log-rank (Mantel-Cox) test (k) or one-way ANOVA with Sidak’s test (a, l). Source data are provided as a Source Data file.
Fig. 7 Synergistic antifungal effect of CPTH2 and CAS against C. auris in vitro and in vivo. a Histone H3 acetylation levels in C. auris CBS12767 were assessed by Western blot following treatment with increasing concentrations of CPTH2 or DMSO control. Results are representative of three independent experiments. b Spot assays show the individual and combined antifungal effects of CPTH2 (0.5 μM) and CAS (31.25 ng/mL for CBS12767; 4 μg/mL for yCB799) against C. auris CBS12767 and yCB799. c, d Checkerboard assays evaluated CPTH2 and CAS combinations against CBS12767 (c) and yCB799 (d). FICI values are shown in the upper right corners. e, g Time-kill curves for CPTH2 and CAS, alone or in combination, were generated for CBS12767 (e) and yCB799 (g). Combo1 and Combo2 indicate 4 μM CPTH2 with 7.8 or 31.25 ng/mL CAS (e), and 6 μM CPTH2 with 8 or 128 μg/mL CAS (g). Data are representative of three independent experiments. f, h Colony formation after 48-h drug exposure (alone or combined) and plating on drug-free SDA medium, followed by 36-h incubation at 30 °C for CBS12767 (f) and yCB799 (h). i, j Checkerboard assays demonstrate synergistic activity of CPTH2 and CAS against clinical isolates from five C. auris clades (i) and the gcn5Δ−2 mutant (j), with FICI values in the upper right corner; I, II, III, IV, and V represent Clades I–V. k Survival analysis of Galleria mellonella larvae (n = 20) infected with yCB799 and treated with CPTH2 alone (upper panel) or CPTH2 and CAS alone or in combination (lower panel). l Fungal burden measured in the spleens and liver of mice infected with yCB799 after 6 treatments with CPTH2 (10 mg/kg, n = 6; 40 mg/kg, n = 8) and CAS (10 mg/kg), either alone or in combination. Data presented in (a–k) are expressed as mean ± SD. Statistical significance analysis was performed using Log-rank (Mantel-Cox) test (k) or one-way ANOVA with Sidak’s test (a, l). Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 8 Safety assessment of targeting Gcn5 in the host. a Western blot analysis of histone H3K9 acetylation levels in HeLa cells treated with various concentrations of CPTH2 or an equivalent volume of DMSO for 24 h. Results are representative of three independent experiments. b Detection of LDH release in HeLa cells following treatment with different concentrations of CPTH2 or an equivalent volume of DMSO for 24 h (n = 6). Cell lysis solution was added 45 min before detection as a positive control (n = 4). Data are presented as the ratio of LDH release in the experimental group to the control group. c Survival of Galleria mellonella larvae over 7 days following injection with different concentrations of CPTH2 or DMSO (n = 20). d Body weight monitoring in mice receiving daily intraperitoneal injections of 10, 20, or 40 mg/kg CPTH2, or solvent control, for 4 days (n = 4). e Serum levels of ALT, AST, CREA, BUN, and LDH measured 24 h after the final injection in the 40 mg/kg group and control mice (n = 4). f Histological analysis of kidney and liver tissues in all 4 mice from each group, with consistent results observed across individuals. Data presented in (a–d) are expressed as mean ± SD. Statistical significance analysis was performed using one-way ANOVA with Sidak’s test. Source data are provided as a Source Data file.
Fig. 8 Safety assessment of targeting Gcn5 in the host. a Western blot analysis of histone H3K9 acetylation levels in HeLa cells treated with various concentrations of CPTH2 or an equivalent volume of DMSO for 24 h. Results are representative of three independent experiments. b Detection of LDH release in HeLa cells following treatment with different concentrations of CPTH2 or an equivalent volume of DMSO for 24 h (n = 6). Cell lysis solution was added 45 min before detection as a positive control (n = 4). Data are presented as the ratio of LDH release in the experimental group to the control group. c Survival of Galleria mellonella larvae over 7 days following injection with different concentrations of CPTH2 or DMSO (n = 20). d Body weight monitoring in mice receiving daily intraperitoneal injections of 10, 20, or 40 mg/kg CPTH2, or solvent control, for 4 days (n = 4). e Serum levels of ALT, AST, CREA, BUN, and LDH measured 24 h after the final injection in the 40 mg/kg group and control mice (n = 4). f Histological analysis of kidney and liver tissues in all 4 mice from each group, with consistent results observed across individuals. Data presented in (a–d) are expressed as mean ± SD. Statistical significance analysis was performed using one-way ANOVA with Sidak’s test. Source data are provided as a Source Data file.CC BY · PubMed Central

Verification

Claims the paper makes

15 Valid · 0 Not valid · 7 Not checked · 147 Own results and interpretations

115 more claims · 4 with their cited sources checked

Create a free account to see all 169 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 33
  • Probably not a substantial claim. 17

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Show all 81 references

Research works printed but not linked: 2

  1. Bing, J. et al. Experimental evolution identifies adaptive aneuploidy as a mechanism of fluconazole resistance in Candida auris. Antimicrob. Agents Chemother. 65, 01466–01420 (2020). · DOI · Paper page
  2. Yu, S. et al. Histone acetylation regulator Gcn5 mediates drug resistance and virulence of Candida glabrata. Microbiol. Spectr. 10, e0096322 (2022). · DOI · Paper page

Cited by

See all 33

Metadata

Authors
Zhang, Y., Zeng, L., Huang, X., Wang, Y., Chen, G., Moses, M., Zou, Y., Xiong, S., Xue, W., Dong, Y., Tian, Y., Guan, M., Hu, L., Yin, Z., Zhou, D., Huang, X., & Chen, C.
Affiliations
  • Nanchang University (CN)
  • Chinese Academy of Sciences (CN)
  • Chinese People's Armed Police Force (CN)
  • Shanghai Medical College of Fudan University (CN)
  • Academy of Military Medical Sciences (CN)
Corresponding author
  • Huang, Xinhua
  • Zhou, Dongsheng
  • Huang, Xiaotian
  • Chen, Changbin
Venue
Nature Communications
Published
2025-05-20
Volume
16
Issue
1
Pages
4668-4668
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4410521054
Cited by
33
References
80
Citations by year
2026: 23 · 2025: 10
FWCI
25.17
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (32060040, 32170195, 32460049)
  • Chinese Academy of Sciences
  • Government of Jiangsu Province
  • Fudan University
  • Nanchang University
  • Stockholms Universitet
  • Science for Life Laboratory
  • Huashan Hospital
  • Recruitment Program of Global Experts
  • State Key Laboratory of Pathogen and Biosecurity
  • Institute of Microbiology, Chinese Academy of Sciences
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
Keywords
Candida auris, antifungal resistance, histone acetylation, GCN5, Rtt109, histone methylation, Set1, Set2, Dot1, ergosterol biosynthesis, drug efflux, azole susceptibility, echinocandin resistance, calcineurin signaling, cell wall integrity, fungal virulence, epigenetic drug targets, invasive fungal infections
MeSH terms
Caspofungin, Candida auris, Acetylation, Animals, Antifungal Agents, Candidiasis, Cell Wall, Fungal Proteins, Histones, Humans, Microbial Sensitivity Tests, Moths, Virulence, Gene Expression Regulation, Fungal, Drug Resistance, Fungal, Epigenesis, Genetic, Mice, Histone Acetyltransferases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeting epigenetic regulators to overcome drug resistance in the emerging human fungal pathogen Candida auris. https://app.cochat.ai/papers/10.1038/s41467-025-59898-6
The paper
Zhang, Y., Zeng, L., Huang, X., Wang, Y., Chen, G., Moses, M., Zou, Y., Xiong, S., Xue, W., Dong, Y., Tian, Y., Guan, M., Hu, L., Yin, Z., Zhou, D., Huang, X., & Chen, C. (2025). Targeting epigenetic regulators to overcome drug resistance in the emerging human fungal pathogen Candida auris. Nature Communications. https://doi.org/10.1038/s41467-025-59898-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.